Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025.

Transaction significantly expands GATX's scale and further diversifies its North American railcar portfolio CHICAGO--(BUSINESS WIRE)--GATX Corporation (NYSE: GATX) today announced the successful closi ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Thomas J Catalano is a CFP and Registered ...

Learn about acquisition adjustments, their role in M&A premiums, and how they impact asset valuation, depreciation, and corporate taxes.

There was a time most maintenance and EAM software operated strictly within a facility or enterprise, but the development of ...